| Filed | Description | |
|---|---|---|
| 11/20/25 | 1.012.03 Material Agreement · New Debt Obligation | → |
| 10/31/25 | 1.012.03 Material Agreement · New Debt Obligation | → |
| 10/30/25 | 1.01 Material Agreement | → |
| 12/26/24 | 1.012.03 Material Agreement · New Debt Obligation | → |
| 11/1/24 | 1.012.03 Material Agreement · New Debt Obligation | → |
| 6/4/24 | 1.01 Material Agreement | → |
| ↓ 26 more | ||
Northwest Biotherapeutics, Inc. is a development-stage American pharmaceutical company headquartered in Maryland that focuses on developing immunotherapies against different types of cancer.